Taysha Gene Therapies's total assets for Q4 2024 were $160.36M, a decrease of -11.02% from the previous quarter. TSHA total liabilities were $88.84M for the fiscal quarter, a -2.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.